Looking for 52-51-7 / Bronopol API manufacturers, exporters & distributors?
Bronopol manufacturers, exporters & distributors
1
45
PharmaCompass offers a list of Bronopol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bronopol manufacturer or Bronopol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bronopol manufacturer or Bronopol supplier.
PharmaCompass also assists you with knowing the Bronopol API Price utilized in the formulation of products. Bronopol API Price is not always fixed or binding as the Bronopol Price is obtained through a variety of data sources. The Bronopol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
API | Excipient name
Bronopol
Synonyms
2-bromo-2-nitro-1,3-propanediol, 52-51-7, 2-bromo-2-nitropropane-1,3-diol, Bronosol, Bronocot, Bronidiol
Unique Ingredient Identifier (UNII)
6PU1E16C9W
About Bronopol
Bronopol, or 2-Bromo-2-nitro-1,3-propanediol, is an organic compound with wide-spectrum antimicrobial properties. First synthesized in 1897, bronopol was primarily used as a preservative for pharmaceuticals and was registered in the United States in 1984 for use in industrial bactericides, slimicides and preservatives. Bronopol is used as a microbicide or microbiostat in various commercial and industrial applications, including oil field systems, air washer systems, air conditioning or humidifying systems, cooling water systems, papermills, absorbent clays, metal working fluids, printing inks, paints, adhesives and consumer products. Compared to other aliphatic halogen-nitro compounds, bronopol is more stable to hydrolysis in aqueous media under normal conditions. The inhibitory activity against various bacteria, including Pseudomonas aeruginosa, was demonstrated in vitro. The agent is largely available commercially as an antibacterial for a variety of industrial purposes while it is predominantly available for purchase as a pet animal litter antibacterial at the domestic consumer level. Nevertheless, ongoing contemporary re-evaluations of bronopol use in large markets such as Canada now place various compositional and product restrictions on the use of the agent in cosmetic products and in other products where it may not primarily be used in the role of a non-medicinal preservative antimicrobial.